$GRCU Daily Chart

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 24

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 2

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Updated Category News Views 72

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Continue Reading
Netcapital's Revenue Fraud Scandal Hits Investor Confidence

Updated Category News Views 28

The Rise and Fall of Netcapital: A Troubling Drop Netcapital Inc. (NASDAQ: NCPL) has found itself in hot water with investors after revelations of a wild scheme to fluff up its revenue figures. It’s like watching a house of cards crumble — and investors are left holding the bag. From December 15, 2021, through September 3, 2026, a slew of misinformation allegedly...

Continue Reading
HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 7

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading
Aberdeen's Reverse Split: What Investors Need to Know

Updated Category News Views 31

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Continue Reading
KarbunWise Unveils Game-Changing LCA Tool at Greenbuild

Updated Category News Views 13

Disruptive Tech Meets Green Standards New York got hit with a sustainability tidal wave at this year’s Greenbuild Expo. KarbunWise is making some serious noise with their new platform that's all about minimizing the carbon footprint in construction projects—there’s nothing passive about it. If you haven't heard, the Expo theme is “Invest for Impact,” which is...

Continue Reading
Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 22

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 51

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading

Top 5 Most Recently Viewed Articles

Rubico Inc. Secures Time Charter Extensions to Enhance Revenue

Updated Category News Views 140

Rubico Inc. Expands Financial Outlook with Charter Extensions Rubico Inc. has made headlines recently as it announces the extension of time charters for both of its modern tanker vessels, supporting its steady growth in the shipping industry. Known for its eco-friendly, fuel-efficient tanker vessels, this move reflects the company's commitment to optimizing its...

Continue Reading
Exploring High-Yield Dividend Stocks in the Industrials Sector

Updated Category News Views 187

Investing in Dividend-Yielding Stocks During turbulent times in the financial markets, investors often seek refuge in dividend-yielding stocks. These stocks are typically from companies with strong free cash flows that reward their shareholders. In particular, high-yield dividend stocks can be an attractive option for those looking to generate income from their...

Continue Reading
Foventa Therapeutics: Spotlight on Diabetic Eye Treatment

Updated Category News Views 25

Foventa's Shift: From Science to Clinical Focus Well, isn't this a twist of fate? Exonate, the company that once thrived on cutting-edge science, is shedding its old skin and stepping into a new spotlight as Foventa Therapeutics. The old moniker is in the rearview, and now they're pledging to tackle non-proliferative diabetic retinopathy (NPDR) with a fresh angle—a...

Continue Reading
Elevating Patient Care: Viz.ai and Illuminate Unite Forces

Updated Category News Views 180

Innovative Partnership Between Viz.ai and Illuminate In a significant stride for patient care, Viz.ai has announced a collaborative expansion with Illuminate, a company renowned for its advancements in AI and natural language processing. This partnership aims to revolutionize the identification and monitoring of patients with cerebral aneurysms, facilitating timely...

Continue Reading
Trilogy Metals Shares Fiscal Insights and Project Developments

Updated Category News Views 328

Trilogy Metals Shares Fiscal Insights and Project Developments Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ), a notable player in metal exploration, recently announced its financial results for the third quarter ending August 31, 2025. The latest updates detail the company's fiscal health, progressive projects, and future outlook, revealing a net loss of $1.7...

Continue Reading